Genetic Signatures Limited
Save
122.15M
Market cap
Current P/E
54.95x
Forward P/E

About

Health care
Sector
Diagnostics & Research
Industry

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens.

Similar securities

Based on sector and market capitalization

Report issue